Announcement: CAP Accreditation

Monday, March 27th, 2017

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Viafet Genomics Laboratory based on results of a recent on-site inspection as part of the CAP's Accreditation Programs. By obtaining this accreditation, Viafet became the first genetics laboratory CAP accredited for Next Generation Sequencing technologies in the Middle East and GCC. During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

"This is an achievement for our laboratory, for the UAE healthcare sector, and for the GCC and Middle East, as Viafet is the first laboratory in the region to obtain CAP accreditation for Next Generation Sequencing services. This accreditation is one more step towards the continual goal of affirming the UAE as a global hub for quality genetic testing services," said Dr. Ali Hellani, the Laboratory Director and Founder of Viafet.

Accreditation is an important metric of a laboratory's quality standard and by pursuing accreditation with the CAP, Viafet established their quality benchmark alongside leading laboratory and medical facilities worldwide and solidfied their position as the leader of genetic testing in the UAE. Laboratory services include Whole Exome Sequencing, Carrier Screening, Pre-Implantation Genetic Screening and Diagnosis, Invasive Prenatal Testing of CVS or Amniotic Fluid, Products of Conception Screening, Targeted Mutation Screening through Sanger Sequencing, and more.

About Viafet

Viafet is a diagnostic genetic laboratory based in Dubai with all testing being performed in-house in the UAE since 2012. Viafet is the only laboratory performing Whole Exome Sequencing and Carrier Screening in the UAE. In addition, Viafet provides Pre-Implantation Genetic Screening and Diagnosis services to the majority of In Vitro Fertilization centers in the UAE and is recognized as a global leader in genetic testing, particularly Reproductive Genetics, receiving on average more than 2,500 embryo biopsies for testing a month. To-date, more than 12,500 patient tests have been performed in collaboration with more than 45 medical partners in the GCC and Middle East.